Representative Gilbert Ray Cisneros, Jr. (D-California) recently sold shares of Danaher Co. (NYSE:DHR). In a filing disclosed on March 06th, the Representative disclosed that they had sold between $1,001 and $15,000 in Danaher stock on February 26th. The trade occurred in the Representative’s “150 MAIN STREET TRUST > BANK OF AMERICA” account.
Representative Gilbert Ray Cisneros, Jr. also recently made the following trade(s):
- Purchased $1,001 – $15,000 in shares of Sterling Infrastructure (NASDAQ:STRL) on 3/3/2025.
- Purchased $1,001 – $15,000 in shares of Hillman Solutions (NASDAQ:HLMN) on 3/3/2025.
- Sold $1,001 – $15,000 in shares of Ford Motor (NYSE:F) on 2/26/2025.
- Purchased $1,001 – $15,000 in shares of Uber Technologies (NYSE:UBER) on 2/26/2025.
- Sold $15,001 – $50,000 in shares of UnitedHealth Group (NYSE:UNH) on 2/26/2025.
- Purchased $15,001 – $50,000 in shares of Microsoft (NASDAQ:MSFT) on 2/26/2025.
- Sold $1,001 – $15,000 in shares of General Motors (NYSE:GM) on 2/26/2025.
- Purchased $1,001 – $15,000 in shares of Tesla (NASDAQ:TSLA) on 2/26/2025.
- Sold $1,001 – $15,000 in shares of Akamai Technologies (NASDAQ:AKAM) on 2/26/2025.
- Purchased $1,001 – $15,000 in shares of Dollar General (NYSE:DG) on 2/26/2025.
Danaher Price Performance
Shares of DHR stock traded down $2.46 during trading on Friday, hitting $212.35. The company had a trading volume of 5,937,296 shares, compared to its average volume of 4,647,188. The stock has a market capitalization of $151.77 billion, a price-to-earnings ratio of 40.22, a price-to-earnings-growth ratio of 2.66 and a beta of 0.82. The stock’s 50-day moving average is $222.51 and its two-hundred day moving average is $243.02. The company has a quick ratio of 1.05, a current ratio of 1.40 and a debt-to-equity ratio of 0.31. Danaher Co. has a 52 week low of $196.80 and a 52 week high of $281.70.
Danaher Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Friday, April 25th. Stockholders of record on Friday, March 28th will be given a dividend of $0.32 per share. The ex-dividend date of this dividend is Friday, March 28th. This is a boost from Danaher’s previous quarterly dividend of $0.27. This represents a $1.28 annualized dividend and a dividend yield of 0.60%. Danaher’s dividend payout ratio is currently 24.24%.
Analyst Upgrades and Downgrades
DHR has been the topic of several recent analyst reports. Barclays dropped their price objective on Danaher from $275.00 to $240.00 and set an “equal weight” rating on the stock in a research report on Thursday, January 30th. Raymond James reaffirmed a “market perform” rating on shares of Danaher in a research note on Monday, February 3rd. Bank of America upgraded Danaher from a “neutral” rating to a “buy” rating and set a $290.00 target price for the company in a report on Friday, December 13th. Guggenheim started coverage on Danaher in a report on Thursday, December 19th. They issued a “buy” rating and a $275.00 target price for the company. Finally, StockNews.com cut Danaher from a “buy” rating to a “hold” rating in a report on Saturday, December 14th. Seven analysts have rated the stock with a hold rating and fifteen have given a buy rating to the stock. According to MarketBeat.com, the stock has an average rating of “Moderate Buy” and an average price target of $278.00.
Get Our Latest Analysis on DHR
Institutional Inflows and Outflows
Large investors have recently made changes to their positions in the company. Heck Capital Advisors LLC acquired a new stake in shares of Danaher during the fourth quarter valued at about $27,000. Decker Retirement Planning Inc. bought a new stake in shares of Danaher during the fourth quarter valued at approximately $31,000. Golden State Wealth Management LLC bought a new stake in Danaher during the fourth quarter worth approximately $31,000. Strategic Financial Concepts LLC bought a new stake in Danaher during the fourth quarter worth approximately $31,000. Finally, Pineridge Advisors LLC grew its position in Danaher by 63.3% in the fourth quarter. Pineridge Advisors LLC now owns 147 shares of the conglomerate’s stock worth $34,000 after buying an additional 57 shares during the last quarter. 79.05% of the stock is owned by hedge funds and other institutional investors.
Insiders Place Their Bets
In other Danaher news, SVP Brian W. Ellis sold 5,700 shares of the business’s stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the completion of the transaction, the senior vice president now owns 20,230 shares of the company’s stock, valued at $4,534,149.90. The trade was a 21.98 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 11.10% of the stock is currently owned by company insiders.
About Representative Cisneros
Gil Cisneros (Democratic Party) is a member of the U.S. House, representing California’s 31st Congressional District. He assumed office on January 3, 2025. His current term ends on January 3, 2027.
Cisneros (Democratic Party) is running for re-election to the U.S. House to represent California’s 31st Congressional District. He declared candidacy for the 2026 election.
Gil Cisneros served in the U.S. Navy as a supply officer from 1994 to 2004. Cisneros earned a bachelor’s degree in political science from George Washington University in 1994, a master’s in business administration from Regis University in 2002, and a master’s degree in urban education policy from Brown University in 2015. His career experience includes working as a logistics manager for Frito-Lay. In 2010, Cisneros won the lottery and became involved in activism and philanthropy, founding a scholarship program for local high school students. In 2021, President Joe Biden (D) appointed Cisneros as under secretary of defense for personnel and readiness.
About Danaher
Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.
Featured Articles
- Five stocks we like better than Danaher
- How Investors Can Find the Best Cheap Dividend Stocks
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
- How to Use the MarketBeat Excel Dividend Calculator
- 3 Stocks to Buy While Others Stay on the Sidelines
- Want to Profit on the Downtrend? Downtrends, Explained.
- MarketBeat Week in Review – 03/03 – 03/07
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.